About ABIC 2018
As the BioPharma industry grows in China & the
Asian region. A part of our highly successful Biopharma series, the event,
which attracts over 300 attendees, is the leading industry platform for
Biopharma, biotech, Manufacturing Equipments, Bioscience and
Analytical Equipments,Facility Design,
Cold Chain, CMOs, CROs, Research institutes, investors,Technology and industry
stakeholders to meet, network and discuss current industry trends, establish
business partnerships and be updated on investment opportunities in China.
Covering topics ranging from latest regulations
impacting to International partnering;from Biosimilar to CMO and Clinical development,from Protein engineering
technology to Antibody development,from Biomanufacturing to Bioprocessing; from Upsteam: Cell Culture and Cell Line Development to Downstream: Protein
Purification, Expression & Characterization; from Cutting edge
technology & solutions to best Practice case studies;from business strategy, investment to innovation.
This
is probably the most important event in the year on biopharma in terms of
participants. It cannot be missed.
With over 40 speakers and estimation to bring over 300
Biopharma professionals, the key congress topics will cover:
• New investment and outlook in china biopharma industry, Biotech Innovation
and regulatory compliance
•• Facility Innovations In design, technology and flexibility, Innovation in
technologies and manufacturing process
• Advancements on scale-up, production, purification,
expression technologies, quality control
•Discuss the advanced strategy and solutions to
enhance biosimilars’ bioprocessing stability and reliability
•Summarize the experience from clinical trials’
design, statistics, tests, indications and etc to quicken biosimilars’ clinical
development
•Examine advances in Innovation & Technology
for Biosimilar Development，Overlook the market access and clinical accessibility
for future biosimilars
•Antibody & protein structure design and optimization，Leading
protein and antibody engineering technology and innovational application
• Functional and Analytical Characterization of Host Cell
Lines, Analytical Methods and Formulation Strategies and Technologies
• Innovative approaches and optimization in early cell line development and
media
• Following up the updated R&D progress of new
structural antibody, and protein under different indications
On behalf of the committee, we sincerely hope
primary discussions, topics and invitees would come across your scientific and
strategic interests and the whole summit will be consisted of keynote speeches,
panel/roundtable discussions, open Q&A sessions, booth and poster
exhibition and guided networking sessions for all professionals and management
who are working for the Biopharma industry in Asia
Who should attend?
More than 300 participants are expected to attend “The
3rd Biopharma Innovation Conference 2018, attracting the strong contingent
throughout the Asia Pacific, USA and Europe.
To breakdown, the participants will mainly come from:
By Job Title:
Chief Executives,
Scientists, Directors, General
Managers and Heads of:
• Antibody Research and Development
• Antibody Technology
• Immunology
• Cancer / Autoimmune Research
• Biopharmaceutical Research
• Bio-analytical science
• Regulatory affairs
• Preclinical/clinical research and development
• Biosimilars
• Licensing
• Business Development
• Antibody Purification
• Chief technology officers
• Process development
• Manufacturing
• External manufacturing/manufacturing network
• Quality assurance/quality control
• Technical operations
• Cell culture
By Industry:
·Biopharmaceutical Companies
·Vaccine/Antibody Companies
·Biotech Companies
·Generics
• Manufacturing solution providers (upstream,downstream)
·Bioscience and Analytical Equipments
·Diagnostic and Testing Equipments
·Facility Design
·Protein Drug Companies
• Contract service providers (CROs, CMOs,CDMOs)
• Facility HVAC, cleanroom and containment equipment providers
• Country governments / trade agencies
·Lab Equipment Suppliers
• Legal and compliance firms
• 3rd party logistics providers
• Cold chain packaging companies
• Distributors in Asia Pacifi c
• Executive search firms
• Laboratory equipment providers
• Bio Parks
Who Should Sponsor?
• Contract Manufacturing Organizations
• Contract Research Organizations
• Cell Culture and Media / Cell Lines Solutions Provider
• Disposable Technology Providers
• Purification Technology Providers
• Bioprocess Technology Providers
• Automation Technology Providers
• Process Analytical Technology (PTA) Providers
• Consultants in Process and Plant Design
• Construction and Engineering Services
• Equipment Providers
• Biologics Technology Platforms/Biotechs
• Distribution and Logistics
• Cold Chain Storage
• Regional Development Agencies
• Reagent Providers
• Packaging, Fill and Finish Service Providers
• Consultants (Law, Auditing)
第三届2018生物制药创新国际峰会
随着生物制药行业在中国及亚洲地区的发展，做为我们非常成功的生物制药峰会系列的一部分,本次峰会将吸引超过300位生物制药领域的企业高层管理者参与，80%的参会者为总监级别以上职位。绝大多数参会者来自跨国或本土的生物制药企业、生物技术公司、生产设备公司、技术解决方案提供商、厂房设计与建造公司、医药品制造受托机关（CMO）、研究机构、投资者、供应链管理提供商、技术及产业利益相关者、相关政府官员及大学教授每年也竞相参与本会议。寻求新的商业合作机会并与行业同行们交流学习如何解决当前行业热点问题及挑战，如最新法规解读与影响，国际合作创新，生物仿制药的机遇与挑战，抗体开发和商业化运作策略，介绍降低成本的技术并探讨最佳实践，以满足亚洲生物制剂产品增长的需要。主要生物制剂制造商将分享其经验教训、挑战和策略，以推动和完善本行业的发展。本次会议还旨在为主要业界专家提供一个平台，以便深入探讨生物药品制造设施、工艺和质量方面的课题。明确监管途径，评估商业模式、风险和投资机会，定价和商业化战略以及成功案例。就生物技术及实验成果、工艺优化与研发平台技术以及新一代抗体等话题进行分享，以更好地促进产学研交流。
如果您期望与亚洲生物制药领域的决策者们会面及交流学习，这里将是您唯一正确的选择。令您及您的团队始终处于亚洲生物制药发展最前沿，尽在2018年9月19-20日的第三届生物制药创新国际峰会，期待您的参与！
届时峰会将有国际主题演讲，产业及学术报告，众多交流机会，将为高端科技及商业探讨打造一个互动的平台。我们欢迎阁下致电我们86-21-31602153获取更多信息，请登录我们的会议网站www.bioinnovationforum.com 或把您的问题发送至我们电邮marketing@wbfgroup.com 。
Event Name: The 3rd Annual Biopharma Innovation Conference 2018
Date: September 19th to 20th,2018
Venue: Wyndham
Bund East Shanghai,China
Contact
Person:Marketing Department
Direct Line:86 21 31602153
Email:Marketing@wbfgroup.com
Website: www.bioinnovationforum.com
联系方式
联系人：Sky
地址：上海
手机：
电话：
Email：
